| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 24,778,000 | 29,192,000 | 32,045,000 | 41,527,000 | | Cost of Revenue | 21,662,000 | 26,653,000 | 24,999,000 | 39,996,000 | | | Gross Profit | 3,116,000 | 2,539,000 | 7,046,000 | 1,531,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,727,000 | 4,456,000 | 4,574,000 | 7,319,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 402,000 | 533,000 | 399,000 | 599,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,013,000) | (2,450,000) | 2,073,000 | (6,387,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,456,000 | (411,000) | (340,000) | (96,000) | | Earnings Before Interest And Taxes | 316,000 | (2,807,000) | 1,842,000 | (6,619,000) | | Interest Expense | 1,936,000 | 2,343,000 | 2,382,000 | 2,415,000 | | Income Before Tax | (1,620,000) | (5,150,000) | (540,000) | (9,034,000) | | Income Tax Expense | (204,000) | 874,000 | (462,000) | (446,000) | | Minority Interest |
-
| 48,000 | (51,000) | (89,000) | | | | Net Income From Continuing Ops | (1,416,000) | (5,976,000) | (129,000) | (8,677,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 10,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,416,000) | (5,976,000) | (129,000) | (8,667,000) | | Preferred Stock And Other Adjustments | (11,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,427,000) | ($5,976,000) | ($129,000) | ($8,667,000) |
|
0.45% Nasdaq 
0.20%
Income Statement
